pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
tactiva-therapeutics PRESS RELEASE ARCHIVE
Dec 3, 2018
Tactiva Therapeutics Secures $35 Million Series A Financing to Pursue Clinical Development of DEACT Platform
Nov 26, 2018
Tactiva Therapeutics Announces License to Oncolytic Vaccinia Virus Armed With CXCR4 Antagonist for Treatment of Ovarian Cancer
Oct 18, 2018
Tactiva Therapeutics Co-Founder Kunle Odunsi Elected to National Academy of Medicine
Dec 14, 2017
Tactiva Therapeutics to Present at Biotech Showcase 2018
Aug 31, 2017
Tactiva Therapeutics to Present Positive Data on Novel Dual CD4/CD8 T Cell Receptor in Preclinical Models of Cancer at BioCentury's 24th Annual Newsmakers Conference
May 15, 2017
Tactiva Therapeutics Presents Positive Data on Novel Dual CD4/CD8 T Cell Receptor in Preclinical Models of Cancer
